IL1B and infection: Although the biological activities of mycolactone during infection are thought to mediate immunosuppressive effects, recent studies have shown that exposure to a low dose of mycolactone can trigger NLRP3 inflammasome activation resulting in IL-1β release from LPS-primed human macrophages [21,22].